Fibrinogen Survival in Cirrhosis: Improvement by 'Low Dose' Heparin
Authors:
- 1 July 1975
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 83 (1) , 79-81
Abstract
The effect of "low dose" heparin therapy on fibrinogen survival in patients with cirrhosis was studied in six patients. Survival of I-125 radiolabeled fibrinogen was measured using both autologous and homologous material. Average fibrinogen half-life before heparin therapy was 52 hours and after 3000 units of intravenous heparin every 6 hours was 101.8 hours. Median survival before heparin therapy was 56 hours and after therapy was 91 hours. In every instance fibrinogen survival was improved by heparin administration. These data indicate that "low dose" heparin improves fibrinogen survival in cirrhosis and suggest that disseminated intravascular coagulation is a primary process in the defibrination syndrome associated with cirrhosis.Keywords
This publication has 15 references indexed in Scilit:
- EARLY AND INTENSIVE THERAPY OF INTRAVASCULAR COAGULATION IN ACUTE LIVER FAILUREThe Lancet, 1971
- LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSISThe Lancet, 1971
- Biological Properties of the Naturally Occurring Plasma Inhibitor to Activated Factor XJournal of Biological Chemistry, 1971
- Simultaneous Fibrinogen and Platelet’ Survival with [75Se]Selenomethionine in ManBritish Journal of Haematology, 1970
- INTRAVASCULAR COAGULATION IN ACUTE HEPATIC NECROSISThe Lancet, 1970
- Liver Transplantation in Man—IV, Haemorrhage and ThrombosisBMJ, 1969
- Coagulation factors in chronic liver diseaseJournal of Clinical Pathology, 1969
- Hepatic removal of activated factor X by the perfused rabbit liverAmerican Journal of Physiology-Legacy Content, 1968
- Turnover of 131I‐Labelled Fibrinogen in Man: Studies in Normal Subjects, in Congenital Coagulation Factor Deficiency States, in Liver Cirrhosis, in Polycythemia Vera and in Epidermolysis Bullosa1Acta Medica Scandinavica, 1966
- Coagulation Disturbances with Manifest Bleeding in Extrahepatic Portal Hypertension and in Liver CirrhosisActa Medica Scandinavica, 1963